Multicenter clinical trial of head and neck carcinoma in Japan clinical oncology group (JCOG)

  • TAHARA Makoto
    Division of Digestive Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East

Bibliographic Information

Other Title
  • 日本臨床腫瘍研究グループ (JCOG) における頭頸部腫瘍に対する多施設共同臨床試験

Search this article

Description

The Japan clinical oncology group (JCOG) is a cooperative oncology group with the aims of establishing the standard of cancer treatment, mainly in solid cancer. To ensure a quality of clinical trials, quality control (QC) and quality assurance (QA) have been performed in JCOG. Although JCOG consists of thirteen clinical study groups, none of them has conducted clinical trial of head and neck cancer. We are planning to conduct a multicenter phase II trial of chemoradiotherapy (CRT) concurrently with S-1 and cisplatin in patients with unresectable locally advanced head and neck carcinoma as a first JCOG trial of head and neck carcinoma. We hope that this trial give an impulse to increase the number of multicenter clinical trials of head and neck carcinoma in Japan according to understanding of importance of multicenter clinical trials.

Journal

  • OTOLOGIA FUKUOKA

    OTOLOGIA FUKUOKA 51 (5Supplement1), S1-S6, 2005

    JIBI TO RINSHO KAI

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top